Jean‐Michel Culouscou

Author

Also Known As

Culouscou, Jean-Michel, J M Culouscou, J. M. CULOUSCOU, J.-M. Culouscou, J.M. CULOUSCOU, J.M. Culouscou, Jean-Michel Culouscou, Jean‐Michel Culouscou

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Centre National de la Recherche Scientifique Sanofi (France)Aix-Marseille Université Bristol-Myers Squibb (Germany)

About

Jean‐Michel Culouscou is an author at Bristol-Myers Squibb (United States) specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.9K
2	Natural Sciences	3	3	841
3	Biochemistry	3	3	841
4	Health Sciences	2	2	182
5	Public Health	1	1	29

Jean‐Michel Culouscou

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Gregory D. Plowman, Jean‐Michel Culouscou, Gena S. Whitney, Proceedings of the National Academy of Sciences Signal TransductionDevelopmental BiologySignaling PathwayLigand-specific ActivationReceptor Tyrosine Kinase	1993	717
Heregulin induces tyrosine phosphorylation of HER4/p180erbB4 Gregory D. Plowman, Janell M. Green, Jean‐Michel Culouscou, Nature Protein FunctionSignal TransductionBiochemistryMolecular RegulationNatural Sciences	1993	442
The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts Pierre Savi, Jean‐Luc Zachayus, Nathalie Delesque-Touchard, Proceedings of the National Academy of Sciences Active MetabolitePlatelet AntagonistCell SignalingBiochemistryLipid Rafts	2006	311
Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia Anne Rémaury, Natalio Vita, S. Gendreau, Brain Research Health SciencesNeurophysiologyMedicinePhysiologyNeurotensin Type 1	2002	137
Identification of three novel members of the calcium‐dependent chloride channel (CaCC) family predominantly expressed in the digestive tract and trachea<sup>1</sup> Magali Agnel, Thierry Vermat, Jean‐Michel Culouscou FEBS Letters	1999	92
Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein. Jean‐Michel Culouscou, M. Shoyab PubMed PathologyCancer BiologyTumor BiologyOncologyInsulin-like Growth Factor	1991	88
Characterization of a breast cancer cell differentiation factor that specifically activates the HER4/p180erbB4 receptor. Jean‐Michel Culouscou, Gregory D. Plowman, Gary W. Carlton, Journal of Biological Chemistry Breast OncologySignaling PathwayMedicineP180erbb4 ActivatorCancer Cell Biology	1993	66
Cloning and characterization of a novel human inwardly rectifying potassium channel predominantly expressed in small intestine Michel Partiseti, Vincent Collura, Magali Agnel, FEBS Letters	1998	66
Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29‐D4 cells Jacques Fantini, J. B. Rognoni, Jean‐Michel Culouscou, Journal of Cellular Physiology	1989	53
Production of insulin‐like growth factor II (IGF‐II) and different forms of IGF‐binding proteins by HT‐29 human colon carcinoma cell line Jean‐Michel Culouscou, M Remacle-Bonnet, Françoise Garrouste, Journal of Cellular Physiology	1990	47

Page 1